Pathogenic WDFY3 variants cause neurodevelopmental disorders and opposing effects on brain size.
WDFY3
brain size
intellectual disability
neurodevelopmental delay
Journal
Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537
Informations de publication
Date de publication:
01 09 2019
01 09 2019
Historique:
received:
08
10
2018
revised:
17
04
2019
accepted:
10
05
2019
pubmed:
22
7
2019
medline:
19
5
2020
entrez:
22
7
2019
Statut:
ppublish
Résumé
The underpinnings of mild to moderate neurodevelopmental delay remain elusive, often leading to late diagnosis and interventions. Here, we present data on exome and genome sequencing as well as array analysis of 13 individuals that point to pathogenic, heterozygous, mostly de novo variants in WDFY3 (significant de novo enrichment P = 0.003) as a monogenic cause of mild and non-specific neurodevelopmental delay. Nine variants were protein-truncating and four missense. Overlapping symptoms included neurodevelopmental delay, intellectual disability, macrocephaly, and psychiatric disorders (autism spectrum disorders/attention deficit hyperactivity disorder). One proband presented with an opposing phenotype of microcephaly and the only missense-variant located in the PH-domain of WDFY3. Findings of this case are supported by previously published data, demonstrating that pathogenic PH-domain variants can lead to microcephaly via canonical Wnt-pathway upregulation. In a separate study, we reported that the autophagy scaffolding protein WDFY3 is required for cerebral cortical size regulation in mice, by controlling proper division of neural progenitors. Here, we show that proliferating cortical neural progenitors of human embryonic brains highly express WDFY3, further supporting a role for this molecule in the regulation of prenatal neurogenesis. We present data on Wnt-pathway dysregulation in Wdfy3-haploinsufficient mice, which display macrocephaly and deficits in motor coordination and associative learning, recapitulating the human phenotype. Consequently, we propose that in humans WDFY3 loss-of-function variants lead to macrocephaly via downregulation of the Wnt pathway. In summary, we present WDFY3 as a novel gene linked to mild to moderate neurodevelopmental delay and intellectual disability and conclude that variants putatively causing haploinsufficiency lead to macrocephaly, while an opposing pathomechanism due to variants in the PH-domain of WDFY3 leads to microcephaly.
Identifiants
pubmed: 31327001
pii: 5536588
doi: 10.1093/brain/awz198
pmc: PMC6736092
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
Autophagy-Related Proteins
0
WDFY3 protein, human
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2617-2630Subventions
Organisme : NICHD NIH HHS
ID : U54 HD079125
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH115347
Pays : United States
Organisme : NICHD NIH HHS
ID : R21 HD067855
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007301
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES012691
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG007301
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Références
Behav Brain Res. 2000 Jun 1;110(1-2):73-81
pubmed: 10802305
Anal Chem. 2002 Oct 15;74(20):5383-92
pubmed: 12403597
Cell Mol Neurobiol. 2003 Oct;23(4-5):727-38
pubmed: 14514027
Anal Chem. 2003 Sep 1;75(17):4646-58
pubmed: 14632076
J Cell Sci. 2004 Aug 15;117(Pt 18):4239-51
pubmed: 15292400
Biochemistry. 2004 Nov 30;43(47):14873-80
pubmed: 15554694
Nat Cell Biol. 2006 Apr;8(4):348-57
pubmed: 16547521
Arch Dis Child. 2006 Aug;91(8):701-5
pubmed: 16861488
Gastroenterology. 2006 Oct;131(4):1218-27
pubmed: 17030191
Genome Res. 2009 Jul;19(7):1316-23
pubmed: 19498102
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590
Genome Res. 2010 Jan;20(1):110-21
pubmed: 19858363
Cell Signal. 2010 May;22(5):717-27
pubmed: 20006983
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Mol Cell. 2010 Apr 23;38(2):265-79
pubmed: 20417604
J Neurodev Disord. 2011 Jun;3(2):162-74
pubmed: 21533542
Neuron. 2012 Apr 26;74(2):285-99
pubmed: 22542183
Traffic. 2013 Jul;14(7):749-66
pubmed: 23521701
PLoS Genet. 2013;9(8):e1003709
pubmed: 23990802
Bioessays. 2013 Dec;35(12):1063-70
pubmed: 24105937
Trends Neurosci. 2014 Feb;37(2):95-105
pubmed: 24387789
Brain. 2014 Jul;137(Pt 7):1863-75
pubmed: 24531625
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Nat Genet. 2014 Sep;46(9):944-50
pubmed: 25086666
Nat Commun. 2014 Sep 08;5:4692
pubmed: 25198012
Nature. 2014 Nov 13;515(7526):216-21
pubmed: 25363768
Genome Res. 2015 Jan;25(1):142-54
pubmed: 25378250
Nat Commun. 2015 Apr 24;6:6718
pubmed: 25907794
Brain. 2015 Jul;138(Pt 7):2034-45
pubmed: 25935724
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Nat Rev Genet. 2016 Jan;17(1):9-18
pubmed: 26503795
Genet Med. 2016 Jul;18(7):696-704
pubmed: 26633542
PLoS Genet. 2016 Mar 23;12(3):e1005919
pubmed: 27008544
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Nat Commun. 2016 Nov 08;7:13316
pubmed: 27824329
J Neurodev Disord. 2016 Dec 5;8:45
pubmed: 27980692
Nat Genet. 2017 Apr;49(4):515-526
pubmed: 28191889
Nat Neurosci. 2017 Apr;20(4):602-611
pubmed: 28263302
Genet Med. 2017 Dec;19(12):1300-1308
pubmed: 28471432
Genome Med. 2017 May 30;9(1):43
pubmed: 28554332
Methods Mol Biol. 2017;1654:39-54
pubmed: 28986782
Am J Hum Genet. 2017 Dec 7;101(6):1013-1020
pubmed: 29220673
J Mol Biol. 2018 Jul 20;430(15):2237-2243
pubmed: 29258817
Sci Rep. 2018 Jul 27;8(1):11348
pubmed: 30054502
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Trends Biochem Sci. 1995 Sep;20(9):374
pubmed: 7482707
Electrophoresis. 1997 Dec;18(15):2714-23
pubmed: 9504803